The fight is on: As US pricing reform advances through Congress, pharma gears up for a brawl

After the Senate passed a major drug pricing reform Sunday, pharma companies are likely readying their legal slings and arrows. Meanwhile, industry watchers remain divided on the bill’s pros and cons.